HCM Marketplace

WEBCAST ON CD

Get a head start on the 2008 Work Plan
The Office of Inspector General's (OIG) annual Work Plan gives you a sneak preview at what the Inspector General will look at in 2008, and where investigators will focus their attention. Pricing issues such as AWP, rebates, and AMP will remain top areas of oversight, according to the Work Plan. The OIG will also focus on the FDA’s oversight of off-label drug promotion and Medicare Part D.

The analysis you need to prepare for the coming year
Listen to this 60-minute Webcast ”Analyzing the 2008 OIG Work Plan: Top areas for pharmaceutical enforcement.”  Leading healthcare attorneys Bruce D. Armon, Esq. (Saul Ewing LLP) and John Reiss, Ph.D., J.D., (Saul Ewing LLP) will apply lessons learned from this year’s work plan to forecast top priorities for 2008. They will also provide insight into the OIG’s budget priorities, as well as the federal government’s perspective on issues affecting the healthcare delivery system.

At the end of this live Webcast, you will be able to:

• Identify the main areas of government oversight in the 2008 OIG Work Plan
• Recognize the OIG’s budget priorities for the coming year
• Minimize federal scrutiny of your pricing practices and Medicare Part D processes
• Understand how much transparency is required in clinical investigations
• Recognize how the OIG’s oversight of administrative activities will impact manufacturers

AGENDA

• OIG focus on the Food and Drug Administration (FDA)
  • Comparison of past and present Work Plans
• Oversight of off-label drug promotion
• Adverse event reporting for medical devices
• Disclosures as they relate to clinical investigations
• Medicare and Medicaid concerns
  • Pricing issues
    • Average wholesale price
    • Average manufacturing price
    • Average sales price
  • Rebate issues
  • Part D
• Impact of OIG oversight on state Medicaid programs
  • How will it affect manufacturers and pharmaceutical companies
• Q & A

MEET THE SPEAKERS
Bruce D. Armon, Esq., Partner, Saul Ewing LLP. Armon practices in Saul Ewing’s business department, and is Chair of the Life Science's Practice Group. He concentrates his practice in corporate healthcare law. Armon has assisted pharmaceutical companies and product manufacturers, physicians, dentists, ancillary providers, and hospitals in a variety of statutory, compliance, contractual, and regulatory matters.

John Reiss, Ph.D., J.D., Partner, Saul Ewing LLP. Reiss concentrates his practice in healthcare matters including developing and implementing various forms of provider networks and managed care arrangements; corporate, partnership, and contractual arrangements and ventures; Medicare, Medicaid, and other insurance coverage and payment issues; developing and implementing compliance audits and plans; FDA drug and device issues; certificate of need, licensure, and other regulatory matters; and medical staff credentialing, disputes, and patient care problems.

WHO SHOULD ATTEND THIS WEBCAST?

• Compliance officers
• Legal counsel
• Regulatory affairs

PROGRAM MATERIALS
You will receive presentation slides and other materials that you can print and distribute to all of your peers at your location. Purchase a CD of the program and listen when you can. It's also a perfect training tool for new staff or as a refresher for veteran staff.

• Webcasts

• Other Life Sciences Products